| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63323-599-30 | 63323-599 | HUMAN PRESCRIPTION DRUG | Deferoxamine | DEFEROXAMINE MESYLATE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20091215 | N/A | ANDA | ANDA078718 | Fresenius Kabi USA, LLC | DEFEROXAMINE MESYLATE | 95 mg/mL | 1 VIAL in 1 BOX (63323-599-30) / 21.1 mL in 1 VIAL |
| 63323-597-10 | 63323-597 | HUMAN PRESCRIPTION DRUG | Deferoxamine | DEFEROXAMINE MESYLATE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20091215 | N/A | ANDA | ANDA078718 | Fresenius Kabi USA, LLC | DEFEROXAMINE MESYLATE | 95 mg/mL | 1 VIAL in 1 BOX (63323-597-10) / 5.3 mL in 1 VIAL |